THE INTERNATIONAL CONFERENCE ON LIVER AND LUNG CANCER:

CURRENT AND FUTURE RESEARCH

Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol

Presides over Opening Ceremony of important conference on cancer research

       On January 8^th, 2019, Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol, President of the Chulabhorn Research Institute (CRI), presided over the opening ceremony of the International Conference on Liver and Lung Cancer: Current and Future Research, which was co-organized by the Chulabhorn Research Institute (CRI) and the US National Cancer Institute (NCI) at the Chulabhorn Convention Center, Bangkok, Thailand.

       Cancer is presently one of the leading causes of mortality globally and in Thailand it is now the number one cause of deaths. Through the leadership and vision of Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol, cancer has been the basis for much of the research conducted at CRI, whether it be anti-cancer properties of natural and synthetic compounds, etiological factors of key cancers in the region, such as liver cancer, or molecular changes and markers associated with different types of cancer. Liver cancer is an important cancer in the northeastern part of Thailand and is the subject of collaborations between researchers in Thailand, including at CRI, the Chulabhorn Hospital, the Thai National Cancer Institute, Chiang Mai University and Khon Kaen University, and the US NCI, in a project entitled, “Thailand Initiative in Genomics and Expression Research for Liver Cancer (TIGER-LC)”.

       The International Conference on Liver and Lung Cancer: Current and Future Research addressed various aspects of cancer research, from biology and etiology to approaches to early detection and diagnosis, as well as targets for therapeutic intervention and treatment. It brought together more than 400 participants, and eminent scientists as invited international speakers from 8 countries, with the keynote lecture entitled, “CAR-T-cell Therapy and Advances in Cancer Immunotherapy” being given by Professor Carl June from the University of Pennsylvania, USA. The scientific programme comprised 25 lectures in 3 major sessions, on (1) population studies on liver and lung cancer; (2) cancer drivers, biomarkers of risk, diagnosis, prognosis and responses to therapy; and (3) translational studies.

       This international conference was organized as a tribute to Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol for Her tireless efforts to promote cancer research and treatment in Thailand through CRI and the Chulabhorn Hospital, which, together, will be a center for research and technology transfer that will lead to effective diagnosis and treatment of cancer in Thailand.

follow » Cancer2019